STOCK TITAN
  1. Home
  2. Sec-filings
  3. SDGR
  4. [SCHEDULE 13G/A] Schrodinger, Inc. SEC Filing

[SCHEDULE 13G/A] Schrodinger, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock SDGR logo
Schrodinger, Inc.

NASDAQ:SDGR

SDGR Rankings

#2989 Ranked by Market Cap
N/A Ranked by Dividends

SDGR Latest News

Jul 18, 2025
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jul 17, 2025
Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target
Jun 27, 2025
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia
Jun 17, 2025
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 12, 2025
Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

SDGR Latest SEC Filings

Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity
Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity
Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity
Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity
Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity

SDGR Stock Data

1.59B
62.51M
2.49%
97.93%
12.67%
Health Information Services
Pharmaceutical Preparations
Link
United States
NEW YORK